A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles. - Wikidata - awgldk - TriplyDB

A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles.

A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles.

http://www.wikidata.org/entity/Q36839268

about

Assisted reproductive technology after the birth of louise brown Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation.Ovarian hyperstimulation syndrome: pathophysiology and prevention.The time interval between hCG priming and oocyte retrieval in ART program: a meta-analysis.Denudation and sperm injection interval timing: impact on outcome of intracytoplasmic sperm injection.Controversies in IVM Comparison of fertilization and embryonic development in sibling in vivo matured oocytes retrieved from different sizes follicles from in vitro maturation cycles.Multiple approaches for individualized fertility protective therapy in cancer patients.In-vitro maturation of human oocytes: before or after vitrification?Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles.Morphokinetics of embryos developed from oocytes matured in vitro Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study.Improvement in in vitro fertilization outcome following in vivo synchronization of oocyte maturation in mice.Reduced developmental competence of immature, in-vitro matured and postovulatory aged mouse oocytes following IVF and ICSI Live birth following serial vitrification of embryos and PGD for fragile X syndrome in a patient with the premutation and decreased ovarian reserve.Embryological aspects of oocyte in vitro maturation.In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report.The definition of IVM is clear-variations need defining.The correlation of cumulus mucification patterns with oocyte maturation rate in vitro in FSH + LH-primed IVM cycles: a prospective study.Occurrence of ovarian follicular dominance during stimulation for IVM impacts usable blastocyst yield.Dual Triggering With Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate.Concomitant ovarian drilling and oocyte retrieval by laparoendoscopic single-site surgery led to live birth using in vitro maturation of oocyte and transfer of frozen-thawed blastocyst in woman with polycystic ovary syndrome.In vitro maturation: a five-year experience.Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.What is the optimal condition for fertilization of IVM oocytes?

P2860

Q26851947-8A32E91D-6A55-49C5-9D50-4E97603F2A43 Q30241191-DF30D1C6-EFCB-42BB-ADB2-9A412AFB52D9 Q33743560-8796A043-0941-4DE6-BA58-FA3F18B651BA Q33972642-8A09F109-B2AC-4F52-B37F-E8736FBBD3D4 Q34946492-2A6945CA-42EF-44CF-8131-E123D2A7E44A Q35171101-76A9B617-76C2-40FC-A392-D65D9C0B9F3F Q35171107-AE7E719A-07EA-414F-8B17-0FFEF73BC0DD Q35664417-57904091-5F0B-40C4-BF58-225F39DEC9D0 Q36016261-B0400BC3-BEF1-4A06-B695-49E5B2E5BB37 Q36542509-0050A316-C96E-4C74-99D9-0F62F6CA6D30 Q36594353-5C84E8BA-0F8B-4695-B5D2-644D777B509A Q37024897-E842B32F-318A-43B4-B295-9E7E20ACF13F Q37071485-F095095C-45EE-4756-A456-214B2E1354DF Q37085892-A1452808-C445-4D61-9FB4-BD10D6DC8F97 Q37429884-5D00C3AA-1E89-46D4-A05A-3737730AA307 Q37576658-BBCCA65C-50FA-483B-A282-9707D1C7C256 Q37604607-7509447C-8250-46AF-A1AF-72299F66F276 Q38963451-2650D55F-5CAC-4C23-A99D-DE5BBA7CF5A2 Q48110625-C681C78F-C27C-4970-A529-244F898E5F38 Q48503501-22C31E60-2F36-4248-B0AB-6861DCB23C3B Q48517030-B8EFD486-E5DB-4FF8-B023-B230829767E5 Q48603692-120CEF93-3C42-432F-A887-38C5F406D15A Q48663264-38C484F0-4FFA-4FEF-A21B-9CFE8E097F7F Q52675519-EFA4B308-B2E2-4F65-B82E-497A11DBB232 Q55198034-7388C8BE-7B42-4EB5-92DF-F5668BF4DF13

P2860

A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles.

http://www.wikidata.org/entity/Q36839268

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

A 38 h interval between hCG pr ...... rate in programmed IVM cycles.

@en

type

label

A 38 h interval between hCG pr ...... rate in programmed IVM cycles.

@en

prefLabel

A 38 h interval between hCG pr ...... rate in programmed IVM cycles.

@en

P1433

Q36839268-FDA736C3-636A-417C-A531-4BDE95333287

P1476

Q36839268-5702AB7D-E835-4121-BB20-C592EAAE78F9

P2093

Q36839268-021C14C1-BB90-4BEE-BAEE-5BFCB724C827

Q36839268-24F2ADED-E6E7-437E-8C11-F6ABCA6B3728

Q36839268-3241994A-C630-45B5-A3C5-6E1B58D8A40A

Q36839268-3F567F78-0979-4A5E-B667-A9578E83A5AE

Q36839268-3FF0EF68-806C-4381-8A3A-A7DD3E9949BF

Q36839268-431E8DC0-D7F1-4BB6-9BFE-07F7D48E3DB8

Q36839268-68C92DD6-04A5-451A-A2F0-0400E34EC22A

Q36839268-6E4485F3-8F47-4FCF-8A74-30D240EEBC59

Q36839268-9BF0FF94-4BE4-490D-AC70-135FAE7D74BB

Q36839268-A51BCF18-BBD0-4ACB-8803-8C6B6FB42D20

P2860

Q36839268-0338E13F-75B3-4E5F-9E89-A844FD890F84

Q36839268-0BB61AF5-7E05-48E5-ADBD-6705EA24EE81

Q36839268-13420D0C-4253-43A8-B1D7-340BC1A6706E

Q36839268-1F8638ED-4AF4-409F-B1A1-A05BD88C882E

Q36839268-2D595C28-47BC-4BDA-B783-9630FCF5A7D2

Q36839268-314F0203-7182-4888-A3BC-C9DDA3AC19E0

Q36839268-5A2B9B0A-DEA6-4859-94C7-A1E416AFCF25

Q36839268-64C6415F-83CA-4C1D-A912-006A6B179689

Q36839268-7C0DE151-753A-4AE0-A834-382392B8E97F

Q36839268-7DAA5083-8E75-43AF-AB73-177ECD719D9E

P304

Q36839268-F0DCD2A6-6153-49E6-853E-A0E077C9A61D

P31

Q36839268-E71A9407-F9C5-4FC4-AAF2-F580A0278831

P356

Q36839268-5B4A6E38-17D8-4347-BAD8-25729085A04B

P407

Q36839268-A2E45031-2E22-464E-A87B-A61E25BB4C04

P433

Q36839268-41D19558-3A9F-432A-9723-C793E98D739C

P478

Q36839268-99823D97-2577-4B7B-9E07-81056D2AC144

P577

Q36839268-5395AF9C-D1C0-453E-B691-FB04D4E0359E

P5875

Q36839268-2C05588F-582D-4C6F-AAC6-4F0EBE55C9E4

P698

Q36839268-CBCB333E-C68A-46EA-8AEE-99A48558F9DF

P932

Q36839268-5F6200A4-A489-49E6-B648-A986477DA2A3

P356

P1433

Human Reproduction

P1476

A 38 h interval between hCG pr ...... rate in programmed IVM cycles.

@en

P2093

Belen Herrero

http://www.w3.org/2001/XMLSchema#string

Camille Sylvestre

http://www.w3.org/2001/XMLSchema#string

Ezgi Demirtas

http://www.w3.org/2001/XMLSchema#string

Jin-Tae Chung

http://www.w3.org/2001/XMLSchema#string

Nicola Dean

http://www.w3.org/2001/XMLSchema#string

Ri-Cheng Chian

http://www.w3.org/2001/XMLSchema#string

Seang Lin Tan

http://www.w3.org/2001/XMLSchema#string

Shai Elizur

http://www.w3.org/2001/XMLSchema#string

Weon-Young Son

http://www.w3.org/2001/XMLSchema#string

Yariv Gidoni

http://www.w3.org/2001/XMLSchema#string

P2860

Optimal ICSI timing after the first polar body extrusion in in vitro matured human oocytes

Comparison between two hCG-to-oocyte aspiration intervals on the outcome of in vitro fertilization

Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation.

In vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting the number of immature oocytes retrieved by early follicular phase ultrasonography.

Combination of FSH priming and hCG priming for in-vitro maturation of human oocytes.

Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome.

Comparison of in-vitro maturation cycles with and without in-vivo matured oocytes retrieved.

Pregnancies and deliveries after transfer of human blastocysts derived from in vitro matured oocytes in in vitro maturation cycles.

Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation.

Blastocyst development and pregnancies after IVF of mature oocytes retrieved from unstimulated patients with PCOS after in-vivo HCG priming.

P304

2010-2016

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMREP/DEN210

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5299422

http://www.w3.org/2001/XMLSchema#string

P698

18556681

http://www.w3.org/2001/XMLSchema#string

P932

2517153

http://www.w3.org/2001/XMLSchema#string